Results 1 - 10 of 33 (Click here to explore results)

<

1

2

3

4

>

Recent discoveries and developments of androgen receptor based therapy for prostate cancer. R. Elancheran, V. L. Maruthanila, M. Ramanathan, S. Kabilan, R. Devi, A. Kunnumakara, Jibon Kotoky , Med. Chem. Commun. , 2015 , 6 , 746

NF-κB inhibition promotes apoptosis in androgen-independent prostate cancer cells by the photothermal effect via the IκBα/AR signaling pathway. Chenfei Kong, Miao Hao, Xi Chen, Xiaoming Zhao, Yuqian Wang, Jing Li, Yiyao Gao, Hao Zhang, Bai Yang, Jinlan Jiang , Biomater. Sci. , 2019 , 7 , 2559

Rational design and synthesis of novel phenylsulfonyl-benzamides as anti-prostate cancer agents. Marcella Bassetto, Salvatore Ferla, Gilda Giancotti, Fabrizio Pertusati, Andrew D. Westwell, Andrea Brancale, Christopher McGuigan , Med. Chem. Commun. , 2017 , 8 , 1414

Expression pattern of androgen receptors, AR-V7 and AR-567es, in circulating tumor cells and paired plasma-derived extracellular vesicles in metastatic castration resistant prostate cancer. Areti Strati, Martha Zavridou, Evangelos Bournakis, Sophia Mastoraki, Evi Lianidou , Analyst , 2019 , 144 , 6671

Chemical modulation of transcription factors. Bianca Wiedemann, Jörn Weisner, Daniel Rauh , Med. Chem. Commun. , 2018 , 9 , 1249

Structure–activity relationship analysis of a series of nonsteroidal analogues as androgen receptor antagonists. Miao Yuan, Ping Cheng, Shuping Zhang , New J. Chem. , 2021 , 45 , 1176

Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer. Hyun-Kyung Woo, Juhee Park, Ja Yoon Ku, Chan Ho Lee, Vijaya Sunkara, Hong Koo Ha, Yoon-Kyoung Cho , Lab Chip , 2019 , 19 , 87

Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo–keto reductase 1C3 inhibitory activity. Marina P. Savić, Jovana J. Ajduković, Jovana J. Plavša, Sofija S. Bekić, Andjelka S. Ćelić, Olivera R. Klisurić, Dimitar S. Jakimov, Edward T. Petri, Evgenija A. Djurendić , Med. Chem. Commun. , 2018 , 9 , 969

Novel thiohydantoin analogues bearing the 1-hydroxyl-2,2,2-trifluoro-1-ethyl moiety as androgen receptor inhibitors for the potential treatment of castration resistant prostate cancer. Yingwei Wang, Yufang Deng, Xuehai Pang, Jiang Yu, Lei Fan, Yuanwei Chen, Lifeng Zhao , RSC Adv. , 2017 , 7 , 31866

Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6. Alexandria M. Chan, Steven Fletcher , RSC Med. Chem. , 2021 , 12 , 178